MNOV - MediciNova Inc logo

MediciNova Inc

MNOV

MediciNova Inc. develops small molecule therapeutics targeting neurological disorders like ALS and metabolic diseases, focusing on unmet medical needs. Its pipeline includes MN-166 for neuroprotection and MN-001 for fibrotic conditions, enhancing patient care.

โš•๏ธ Healthcare NASDAQ Listed 2005 $ USD
$1,000 invested 10 years ago โ†’$276today

Score Overview

1 Year
Score
Net Growth10.38%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth124.70%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth-6.11%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-77.20%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth1.04%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend50%
Revenue Consistency
20 Years
Score3.2
Net Growth69.87%
Net Trend55%
Net Income Consistency
Rev Growth248.83%
Rev Trend47%
Revenue Consistency
All Time
Score
Net Growth58.15%
Net Trend52%
Net Income Consistency
Rev Growth14.48%
Rev Trend44%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where MediciNova Inc has ranked, year by year

Measure
Fundamentals Window

Showing 5 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • MNOV

2018: 92.3% ยท 2019: 99.7% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 2.10โ€”
1 Year2025-09-26
$ 1.2765.35%
5 Years2021-09-28
$ 3.91-46.29%
10 Years2016-09-28
$ 7.61-72.40%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 920.48K-$ 10M$ 25.41B
2025$ 409.66K-$ 11M$ 30M
2024$ 0.00-$ 11M$ 40M
2023$ 1M-$ 8M$ 50M
2022$ 0.00-$ 14M$ 58M
2021$ 4M-$ 10M$ 71M
2020$ 4M-$ 13M$ 60M
2019$ 0.00-$ 12M$ 63M
2018$ 0.00-$ 14M$ 62M
2017$ 0.00-$ 11M$ 27M
2016$ 0.00-$ 10M$ 24M
2015$ 0.00-$ 8M$ 22M
2014$ 0.00-$ 9M$ 11M
2013$ 6M-$ 4M$ 6M
2012$ 802.58K-$ 10M$ 4M
2011$ 0.00-$ 17M$ 15M
2010-$ 20M$ 28M
2009-$ 20M$ 46M
2008-$ 21M$ 19M
2007-$ 48M$ 70M
2006$ 263.88K-$ 35M$ 104M
IPO2005$ 804.07K-$ 25M$ 138M
MNOV - MediciNova Inc logo

MediciNova Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 4M to $ 409.66K and net income went from -$ 13M to -$ 11M. Revenue increased in 3 of those 5 years; net income in 2.

Between 2005 and 2025, revenue declined from $ 804.07K to $ 409.66K and net income went from -$ 25M to -$ 11M. Revenue increased in 9 of those 20 years; net income in 11.

MediciNova Inc currently holds a 20-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Continue MNOVโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies